TN2013000231A1 - Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer - Google Patents

Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer

Info

Publication number
TN2013000231A1
TN2013000231A1 TNP2013000231A TN2013000231A TN2013000231A1 TN 2013000231 A1 TN2013000231 A1 TN 2013000231A1 TN P2013000231 A TNP2013000231 A TN P2013000231A TN 2013000231 A TN2013000231 A TN 2013000231A TN 2013000231 A1 TN2013000231 A1 TN 2013000231A1
Authority
TN
Tunisia
Prior art keywords
oxazolo
pyridin
cancer
treatment
compounds
Prior art date
Application number
TNP2013000231A
Other languages
French (fr)
Inventor
David Andrew Coates
Raymond Gilmour
Jose Alfredo Martin
De La Nava Eva Maria Martin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/061099 external-priority patent/WO2012074761A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000231A1 publication Critical patent/TN2013000231A1/en

Links

Abstract

The present invention provides oxazolo[5,4-b]pyridin-5-yl compounds useful in the treatment of cancer.
TNP2013000231A 2011-02-03 2013-05-30 Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer TN2013000231A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161439151P 2011-02-03 2011-02-03
PCT/US2011/061099 WO2012074761A1 (en) 2010-12-03 2011-11-17 Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer

Publications (1)

Publication Number Publication Date
TN2013000231A1 true TN2013000231A1 (en) 2014-11-10

Family

ID=54359563

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000231A TN2013000231A1 (en) 2011-02-03 2013-05-30 Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer

Country Status (1)

Country Link
TN (1) TN2013000231A1 (en)

Similar Documents

Publication Publication Date Title
IL257748B (en) Pyrazolo[3,4-b]pyridine, pyrazolo[4,3-b]pyridine and pyrazolo[3,4-b]pyrazine derivatives for use in the treatment of cancer, inflammation and neurodegenerative diseases " .
MX370814B (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof.
MY158992A (en) Forms of rifaximin and uses thereof
PH12014501844B1 (en) Peptidomimetic macrocycles
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
EP2714081A4 (en) Methods, compositions, and kits for the treatment of cancer
MX349004B (en) New compounds.
EP2580213A4 (en) 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
IL228681A0 (en) 8-ethyl-6-(aryl)pyrido(2,3-d)pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
EP2675469A4 (en) Compositions, devices and methods of use thereof for the treatment of cancers
MX366899B (en) New compounds.
UA117590C2 (en) Solar protection glazing
JO2860B1 (en) Vinyl indazolyl compounds
PH12015501088A1 (en) Dimeric compounds
MX354988B (en) Antibody formulations and methods.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2013006184A (en) Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer.
GEP201706636B (en) Galactagogue compositions based on phosphatidylserine
TN2013000231A1 (en) Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer
TN2011000545A1 (en) Vinyl indazolyl compounds
UA73915U (en) PROCESS FOR THE PREPARATION OF THIAZOLO[4,5-b]QUINOXALINE-2-ONE
UA80819U (en) 2,4-DIAMINO-5-IMINO-10-(4-METHOXYPHENYL)-8-OXO-3-CYANO-7,8,9,10-TETRAHYDRO-5H-PYRIDO[2',3':2,3]THIOPYRANO[4,5-b]PYRIDINE
UA71418U (en) 5,7-DIMETHYL-6-PHENYLAZO-3H-THIAZOLO[4,5-b]PYRIDINE-2-ONE EXHIBITING ANTIEXUDATIVE ACTION
UA58160U (en) use of Lipoflavon for treatment of cerebrovascular trauma